- Home
- GPRO vs PRQR Comparison
GPRO vs PRQR Comparison
Compare GPRO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- PRQR
- Stock Information
- Founded
- GPRO 2004
- PRQR 2012
- Country
- GPRO United States
- PRQR Netherlands
- Employees
- GPRO N/A
- PRQR N/A
- Industry
- GPRO Industrial Machinery/Components
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- PRQR Health Care
- Exchange
- GPRO Nasdaq
- PRQR Nasdaq
- Market Cap
- GPRO 194.6M
- PRQR 224.4M
- IPO Year
- GPRO 2014
- PRQR 2014
- Fundamental
- Price
- GPRO $2.06
- PRQR $2.46
- Analyst Decision
- GPRO
- PRQR Strong Buy
- Analyst Count
- GPRO 0
- PRQR 8
- Target Price
- GPRO N/A
- PRQR $8.88
- AVG Volume (30 Days)
- GPRO 11.4M
- PRQR 431.9K
- Earning Date
- GPRO 11-06-2025
- PRQR 11-06-2025
- Dividend Yield
- GPRO N/A
- PRQR N/A
- EPS Growth
- GPRO N/A
- PRQR N/A
- EPS
- GPRO N/A
- PRQR N/A
- Revenue
- GPRO $746,731,000.00
- PRQR $20,129,184.00
- Revenue This Year
- GPRO N/A
- PRQR N/A
- Revenue Next Year
- GPRO $9.72
- PRQR N/A
- P/E Ratio
- GPRO N/A
- PRQR N/A
- Revenue Growth
- GPRO N/A
- PRQR 8.65
- 52 Week Low
- GPRO $0.40
- PRQR $1.07
- 52 Week High
- GPRO $3.05
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- GPRO 50.47
- PRQR 56.77
- Support Level
- GPRO $1.95
- PRQR $2.08
- Resistance Level
- GPRO $2.53
- PRQR $2.58
- Average True Range (ATR)
- GPRO 0.22
- PRQR 0.17
- MACD
- GPRO -0.06
- PRQR 0.02
- Stochastic Oscillator
- GPRO 27.05
- PRQR 76.60
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.